Alpha DaRT
Phase 2- Indications
- skin cancer, oral cancer, pancreatic cancer, prostate cancer, breast cancer, brain cancer, lung cancer
Company intelligence / Profile preview
Medison Pharma is an active global pharmaceutical company specializing in the commercialization and distribution of highly innovative therapies—especially for rare diseases—in international markets. It operates as a strategic partner for leading biotech and pharma companies seeking to expand their reach outside core markets, providing access to novel treatments across multiple regions. The company does not develop its own drugs but enables access to advanced therapeutics through multi-territorial partnerships[1][3][4].
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Medison Pharma.